18 May 2013
Keywords: abpi/bia, task, force, wake, tgn1412, tragic, adverse
Article | 29 May 2006
In the wake of the tragic adverse reactions to German firm TeGenero's monoclonal antibody drug TGN1412, seen in a trial ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 May 2006
17 May 2013
© 2013 thepharmaletter.com